{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:29Z","timestamp":1792801709475,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2018R1D1A3B07049570"],"award-info":[{"award-number":["2018R1D1A3B07049570"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neuro.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T11:21:28Z","timestamp":1546255288000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Mechanistic comparison between MPTP and rotenone neurotoxicity in mice"],"prefix":"10.1016","volume":"71","author":[{"given":"Sunil","family":"Bhurtel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Katila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabita","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2018.12.009_bib0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuro.2015.03.012","article-title":"The neuroprotective effect of lovastatin on MPP+-induced neurotoxicity is not mediated by PON2","volume":"48","author":"Aguirre-Vidal","year":"2015","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.neuro.2018.12.009_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/0972-2327.104323","article-title":"Hippocampus in health and disease: an overview","volume":"15","author":"Anand","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.neuro.2018.12.009_bib0015","series-title":"Advances in Geroscience","first-page":"229","article-title":"Parkinson\u2019s disease and aging","author":"Andersen","year":"2016"},{"key":"10.1016\/j.neuro.2018.12.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.12964","article-title":"Role of mitochondrial ROS in the brain: from physiology to neurodegeneration","author":"Angelova","year":"2018","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0067-y","article-title":"Novel (Hetero) arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson\u2019s disease","volume":"11","author":"Baranyi","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.neuro.2018.12.009_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2009.11.3\/mbelanger","article-title":"The role of astroglia in neuroprotection","volume":"11","author":"B\u00e9langer","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neuro.2018.12.009_bib0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson\u2019s disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson\u2019s disease: limits and relevance to neuroprotection studies","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuro.2018.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.20848","article-title":"Astrocyte function and role in motor neuron disease: a future therapeutic target?","volume":"57","author":"Blackburn","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuro.2018.12.009_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuro.2018.12.009_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.07.067","article-title":"Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta","volume":"1175","author":"Boyd","year":"2007","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.neuro.2018.12.009_bib0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.neuro.2018.12.009_bib0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuro.2018.12.009_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1267\/ahc.09018","article-title":"Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences","volume":"42","author":"Ehara","year":"2009","journal-title":"Acta Histochem. Cytochem."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.neuro.2018.12.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044610","article-title":"Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death","volume":"7","author":"Giordano","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neuro.2018.12.009_bib0090","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1460-9568.2008.06524.x","article-title":"Brain\u2010derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition","volume":"28","author":"Gomez\u2010Pinilla","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuro.2018.12.009_bib0095","series-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease","first-page":"85","author":"Greenamyre","year":"1999"},{"key":"10.1016\/j.neuro.2018.12.009_bib0100","series-title":"Veterinary Toxicology: Basic and Clinical Principles","author":"Gupta","year":"2012"},{"issue":"9","key":"10.1016\/j.neuro.2018.12.009_bib0105","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease","volume":"137","author":"Hall","year":"2014","journal-title":"Brain"},{"issue":"1-2","key":"10.1016\/j.neuro.2018.12.009_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(99)01273-1","article-title":"Differential strain susceptibility following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus","volume":"828","author":"Hamre","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2018.12.009_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene\u2013environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.neuro.2018.12.009_bib0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","article-title":"Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Katila","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1874609811306010007","article-title":"Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson\u2019s disease: focus on endogenous neurorestoration","volume":"6","author":"L\u2019Episcopo","year":"2013","journal-title":"Curr. Aging Sci."},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-013-0234-1","article-title":"Animal models of Parkinson\u2019s disease: a gateway to therapeutics?","volume":"11","author":"Le","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neuro.2018.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1471-4159.2004.02420.x","article-title":"Pro\u2010regenerative properties of cytokine\u2010activated astrocytes","volume":"89","author":"Liberto","year":"2004","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuro.2018.12.009_bib0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","article-title":"Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"16","author":"Martinez","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nbd.2008.10.001","article-title":"Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo","volume":"33","author":"Meurers","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11064-013-1208-8","article-title":"1-Methyl-4-phenylpyridinium-induced cell death via autophagy through a Bcl-2\/Beclin 1 complex-dependent pathway","volume":"39","author":"Nopparat","year":"2014","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.neuro.2018.12.009_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jnr.21159","article-title":"Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice","volume":"85","author":"Richter","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neuro.2018.12.009_bib0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuro.2018.12.009_bib0170","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1471-4159.2007.05182.x","article-title":"AMP-activated protein kinase phosphorylation in brain is dependent on method of killing and tissue preparation","volume":"105","author":"Scharf","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.neuro.2018.12.009_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(00)02960-7","article-title":"Increased striatal dopamine turnover following acute administration of rotenone to mice","volume":"885","author":"Thiffault","year":"2000","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuro.2018.12.009_bib0190","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson\u2019s disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuro.2018.12.009_bib0195","article-title":"Are rodent models of Parkinson\u2019s disease behaving as they should?","author":"Vingill","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"30","key":"10.1016\/j.neuro.2018.12.009_bib0200","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson\u2019s disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuro.2018.12.009_bib0205","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.modgep.2006.03.009","article-title":"BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan","volume":"6","author":"Webster","year":"2006","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.neuro.2018.12.009_bib0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbr.2014.11.002","article-title":"The rotenone-induced rat model of Parkinson\u2019s disease: behavioral and electrophysiological findings","volume":"279","author":"Wrangel","year":"2015","journal-title":"Behav. Brain Res."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18303978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18303978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:18:45Z","timestamp":1758982725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X18303978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"alternative-id":["S0161813X18303978"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2018.12.009","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic comparison between MPTP and rotenone neurotoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}